Proven To Lower Blood Pressure In 7 Clinical Studies
RESPeRATE's ability to generate a significant and sustained reduction in blood pressure was substantiated in 7 separate clinical studies published in peer-reviewed medical journals.
The studies compared those who used RESPeRATE for 15 minutes a day for 8 weeks to a "control" group, using a walkman with relaxing music1, a home blood pressure monitoring 4,5 or both 2
Clinical studies design included four double-blind and randomized1,2,5,8, one controlled and randomized4, and two open-label studies3,6
There were 286 participants, average age of 58
78% of participants were already taking blood pressure medications, a third of whom were taking more then 3 medications.
Average initial office blood pressure of 150/90 mmHg despite using diet, exercise and/or medications. Buy Now
The results.
RESPeRATE users with uncontrolled blood pressure experienced a significant decrease in office blood pressure by up to 36 points systolic and 20 points diastolic (top 10% reductions) with average reduction of 14/8 mmHg points.
The control treatment reduction was 9/4 mmHg, significantly less than with RESPeRATE.
The results were similar across genders and medication status.
The drop in office BP was directly related to the duration of slow breathing; those who used RESPeRATE more achieved better reductions.
A sustained reduction in blood pressure typically occurred in 3 to 5 weeks.
Larger reductions in office blood pressure occurred in older individuals and those with higher baseline blood pressures, whether taking antihypertensive medication or not.
Home blood pressure measurements (for up to 6 months of use7) and 24-hours ambulatory blood pressure monitoring3 have verified an all-day, lasting blood pressure lowering effect. RESPeRATE's Peer-reviewed Articles :
"Respiration and Blood Pressure." Parati G, Izzo JL Jr, Gavish B., Third Edition. JL Izzo and HR Black, Eds. Baltimore, Lippincott, Williams, and Wilkins in Hypertension Primer, 2003, Ch. A40, p117-120.
FDA clears RESPeRATE
" ..The FDA now says it [RESPeRATE] can be sold over the counter as a means to help people lower their blood pressure.."
WebMD health
RESPeRATE Scientific Board Members
Dr. Cohn has served as president of both the American Society of Hypertension and International Society of Hypertension.
Dr. Weber is the immediate past president of the American Society of Hypertension.
Dr. Pickering, Director, Behavioral Cardiovascular Health and Hypertension Program Columbia Presbyterian Medical Center, New York, NY. Dr. Pickering has served as the secretary of the American Society of Hypertension.
http://www.astenzymes.com
The products and the claims made about specific products on or through this site have not been evaluated by the United States Food and Drug Administration and are not intended to diagnose, treat, cure or prevent disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.